NCT07005726View on ClinicalTrials.gov

BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

6,000

Participants

Timeline

Start Date

May 9, 2025

Primary Completion Date

May 31, 2030

Study Completion Date

July 31, 2030

Conditions
Infant MorbidityInfant MortalityNon-Specific Effects of VaccinesBCG
Interventions
BIOLOGICAL

BCG Vaccine

The WHO-prequalified BCG-Japan or BCG-Denmark

Trial Locations (1)

Unknown

Bandim Health Project, Bissau

All Listed Sponsors
collaborator

University of Southern Denmark

OTHER

collaborator

Radboud University Medical Center

OTHER

lead

Bandim Health Project

OTHER